AGN-214868

· Allergan

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AGN-214868, covering 2013-11-15 to 2020-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia [Phase 2]